Patent details

Title (priority date) Treating cancer by modulating MEX-3 (22.9.2009)
Reference: 53794
Inventors: Ciosk & Kalchhauser
Description: The present invention is based on the finding of a link between the RNA binding protein MEX3 and cell proliferation
Applications: Therapy and Diagnostics
Status: Pending PCT
Opportunity: Exclusive and non-exclusive license
Contact: Dr. Nicolas Favre, tel: +41 61 697 8382,
PCT File: WO 2011/036118
About this site2019 © FMI Basel Switzerland